Techniques & Technology

CHIVA: Theory, Practice and Outcomes

Theory First proposed by Claude Franceschi in the late eighties, CHIVA is the French acronym for “Cure conservatrice et Hemodynamique de l’insuffisance Veineuse en Ambulatoire,” in English “offi...Continue Reading

Big Data. Little Data. More Data. How Our Venous Registries Can Help

by Dr. Steve Elias, Dr. Jens Eldrup-Jorgensen, Dr. Marlin Schul, and Dr. Jack Cronenwett VEIN Magazine Medical Director Dr. Steve Elias is joined by a panel of leading venous disease treatment specialists who are present...Continue Reading

Elusive Deep Venous Disease

Navigating the muddy waters of patient assessment can be one of the most intriguing parts of the job. Whether a patient has tried multiple options or suffered through previous attempts to diagnose and treat the problem w...Continue Reading

Online Learning: In Another Vein

by Julie Cardoso, Ryan Crowder and Eduard Marmut Online learning, also known as e-learning, is the application of the internet and connected electronic devices for the acquisition of knowledge and expertise. It is a proc...Continue Reading

Under Pressure, but How Much? Monitoring Applied Compression Dosages Can Help Improve Patient Care

One who travels the world can truly appreciate enormous variability in care for patients with chronic venous disease among countries, regions, specialties, and providers In these myriads of settings, one treatment modal...Continue Reading

Single Session Venoplasty and Targeted Thrombolysis for Chronic Infrainguinal Venous Obstruction: A Novel Concept

by Raudel Garcia, MD, Paul Gagne, MD, Steve Elias, MD, Nicos Labropoulos, MD and Antonios P. Gasparis, MD Nearly 50 percent of patients with deep venous thrombosis (DVT) develop post-thrombotic syndrome (PTS).1,2 The s...Continue Reading

The Role of Epinephrine in the Treatment of Lower Extremity Reticular and Telangiectatic Veins

by Isabela T. Jones, MD, FAAD and Monique J. Vanaman Wilson, MD Vein specialists have many options when choosing which sclerosants to use for the treatment of lower extremity reticular veins and telangiectasias. In gen...Continue Reading

The Important Role of the Lymphatics in Venous Ulcers: Chronic Wounds May Require More Than Venous Intervention

By Darren J. Wennen MBA*, Daniel Carlson MS, MBA*, and Thomas F. O’Donnell Jr., MD# *Tactile Medical, Minneapolis, Minnesota #Tufts Medical Center, Boston, Mass. and consultant Tactile Medical Contact: TFOD at todon...Continue Reading

The Safety of Foam Sclerotherapy for Reticular Veins: Our Experience

By Elika Hoss, MD and Mitchel P. Goldman, MD Cosmetic Laser Dermatology, San Diego, CA It is estimated that up to 20 percent of adults have varicose veins and up to 50 percent of women will develop telangictasias by the...Continue Reading

Perforators: Fitting Treatment into the Puzzle of Advanced Disease Management

Venous ulcers are a manifestation of chronic venous insufficiency. Up to 2.7% of the Western population has active venous ulcers and a history of venous ulcers that have healed1. The morbidity associated with venous ulcer...Continue Reading